FFA
TARS icon

Farther Finance Advisors’s Tarsus Pharmaceuticals TARS Stock Holding History

Farther Finance Advisors’s Portfolio TARS Stock Details TARS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.69K Buy
24
+1
+4% +$70 ﹤0.01% 4953
2025
Q4 		$1.88K Buy
23
+1
+5% +$75 ﹤0.01% 4716
2025
Q3 		$1.31K Buy
22
+10
+83% +$492 ﹤0.01% 4284
2025
Q2 		$486 Hold
12
– – ﹤0.01% 4044
2025
Q1 		$587 Hold
12
– – ﹤0.01% 3747
2024
Q4 		$664 Hold
12
– – ﹤0.01% 3376
2024
Q3 		$395 Hold
12
– – ﹤0.01% 3476
2024
Q2 		$339 Hold
12
– – ﹤0.01% 3367
2024
Q1 		$430 Hold
12
– – ﹤0.01% 3062
2023
Q4 		$243 Buy
+12
New +$200 ﹤0.01% 3182

Other funds holding TARS

DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $4.89B AUM 251.12% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return